Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Cancer Research Campaign Technology evaluates new antitumor trimelamol analogues

Jan. 19, 1999

Tricyclic antiproliferative agents revealed by Schering-Plough

Jan. 19, 1999

Antitumor candidate originating in Kazakstan slated for development in U.S. and other countries

Jan. 18, 1999

Greater antitumor efficacy and less toxicity obtained with liposomal cisplatin

Jan. 18, 1999

Onyx expands ONYX-015 clinical trials in liver metastases of colorectal cancer

Jan. 15, 1999

Agouron's new MMP inhibitors described in patent literature

Jan. 15, 1999

Another cancer indication targeted for Genta's G-3139: non-Hodgkin's lymphoma

Jan. 14, 1999

Development of cancer treatments targeting apoptosis focus of Idun-Abbott agreement

Jan. 14, 1999

Vanadium complexes claimed by Angiotech for wide range of proliferative disorders

Jan. 14, 1999

Human mindin polypeptides and polynucleotides for angiogenic diseases

Jan. 14, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...